Genzyme moves potential MS therapy closer to FDA finish line with positive Phase 3 data

Genzyme moves potential MS therapy closer to FDA finish line with positive Phase 3 data

Submitted by admin on November 14, 2011 - 12:02pm
Source: 
Bizjournals.com
News Tags: 
Genzyme
MS
multiple sclerosis
FDA
Lemtrada
Headline: 
Genzyme moves potential MS therapy closer to FDA finish line with positive Phase 3 data

Do Not Allow Advertisers to Use My Personal information